Sorafenib N-oxide
An active metabolite of sorafenib

Catalog Number | 27830 |
Alternative Name(s) | BAY 67-3472 |
Research Area | Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Kinase Inhibitors|PDGFR Family||Product Type|Biochemicals|Kinase Inhibitors|RAF||Product Type|Biochemicals|Kinase Inhibitors|VEGFR Family||Product Type|Biochemicals|Small Molecule Inhibitors|Cytochrome P450||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Product Type|Biochemicals|Transporter & Exchanger Modulators||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Death|Ferroptosis||Research Area|Cancer|Cell Signaling|ERK/MAPK Signaling||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling||Research Area|Cell Biology|Cell Death|Ferroptosis||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Hepatitis||Research Area|Oxidative Stress & Reactive Species|Lipid Peroxidation||Research Area|Oxidative Stress & Reactive Species|Reactive Sulfur|Glutathione||Research Area|Toxicology & Xenobiotic Metabolism|Cytochrome P450s|CYP3A4||Research Area|Toxicology & Xenobiotic Metabolism|Drug Metabolites |
Molecular Formula | C21H16ClF3N4O4 |
CAS# | 583840-03-3 |
Purity | ≥98% |
Inchi | InChI=1S/C21H16ClF3N4O4/c1-26-19(30)18-11-15(8-9-29(18)32)33-14-5-2-12(3-6-14)27-20(31)28-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,27,28,31) |
Inchi Key | BQAZCCVUZDIZDC-UHFFFAOYSA-N |
SMILES | ClC1=C(C(F)(F)F)C=C(NC(NC2=CC=C(OC3=CC=[N+]([O-])C(C(NC)=O)=C3)C=C2)=O)C=C1 |
Size | 1 mg |
Supplier Page | https://www.caymanchem.com/product/27830 |